$MNKD My strategy sell off Afrezza probably get $100M and some high single low double digits royalties. You can then drastically cut costs get rid of sales and marketing (whatever that is as they didn't nothing). You can build a high margin very profitable company with $250 million in sales with TreT launch and one other molecule. Then keep signing up new deals. Afrezza is dead with Black Label which was one of the biggest hurdle. BP or big player can maybe get that label taken away while MNKD never will. Afrezza done with MNKD running the program.